DHX PNB 0408 Pure Health Peptides EllieMD Dihexa FDA's Overreach on Compounded Peptides Latest FDA Developments Shaping Clinical Trials in 20252026 Innovative Biologics Expected Biologic Drug Approvals in 2026 FDA Category 2 Update: The 5 Peptides Still Facing Heavy Review As excitement builds around peptides potentially moving off the FDA Category 2 list, it's important to understand one key reality: Not